Literature DB >> 1369015

Isolation, structure determination and biological activity of A-16686 factors A' 1, A' 2 and A' 3 glycolipodepsipeptide antibiotics.

L Gastaldo1, R Ciabatti, F Assi, E Restelli, J K Kettenring, L F Zerilli, G Romanò, M Denaro, B Cavalleri.   

Abstract

When Actinoplanes strain ATCC 33076, the producer of A-16686 A1, A2 and A3 complex, is fermented in a suitable medium three additional factors, designated A' 1, A' 2 and A' 3 are produced. These were isolated and characterized, and were shown to differ from the parent components of the original complex by lacking one mannose unit. Bioconversion of A factors into A' factors was achieved by incubation with the mycelium of Actinoplanes ATCC 33076. Factor A' 2 has better antibacterial activity than A2 against some bacteria.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1369015     DOI: 10.1007/bf01583726

Source DB:  PubMed          Journal:  J Ind Microbiol        ISSN: 0169-4146


  11 in total

1.  Microbial transformation of immunosuppressive compounds. I. Desmethylation of FK506 and immunomycin (FR 900520) by Actinoplanes sp. ATCC 53771.

Authors:  T S Chen; B H Arison; L S Wicker; E S Inamine; R L Monaghan
Journal:  J Antibiot (Tokyo)       Date:  1992-01       Impact factor: 2.649

2.  Microbial transformation of leucomycin A5.

Authors:  K Singh; S Rakhit
Journal:  J Antibiot (Tokyo)       Date:  1979-01       Impact factor: 2.649

3.  A-16686, a new antibiotic from Actinoplanes. II. Biological properties.

Authors:  R Pallanza; M Berti; R Scotti; E Randisi; V Arioli
Journal:  J Antibiot (Tokyo)       Date:  1984-04       Impact factor: 2.649

4.  Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. III. Structure elucidation.

Authors:  R Ciabatti; J K Kettenring; G Winters; G Tuan; L Zerilli; B Cavalleri
Journal:  J Antibiot (Tokyo)       Date:  1989-02       Impact factor: 2.649

5.  Deacylation of echinocandin B by Actinoplanes utahensis.

Authors:  L D Boeck; D S Fukuda; B J Abbott; M Debono
Journal:  J Antibiot (Tokyo)       Date:  1989-03       Impact factor: 2.649

6.  In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycin.

Authors:  N Yamane; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1991 Jul-Aug       Impact factor: 2.803

7.  Deacylation of A21978C, an acidic lipopeptide antibiotic complex, by Actinoplanes utahensis.

Authors:  L D Boeck; D S Fukuda; B J Abbott; M Debono
Journal:  J Antibiot (Tokyo)       Date:  1988-08       Impact factor: 2.649

8.  Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. IV. Complete sequence determination by homonuclear 2D NMR spectroscopy.

Authors:  J K Kettenring; R Ciabatti; G Winters; G Tamborini; B Cavalleri
Journal:  J Antibiot (Tokyo)       Date:  1989-02       Impact factor: 2.649

9.  In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.

Authors:  F Biavasco; E Manso; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

10.  The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.

Authors:  M D O'Hare; D Felmingham; R N Grüneberg
Journal:  Drugs Exp Clin Res       Date:  1988
View more
  3 in total

1.  Additional congeners of the macrolide neaumycin: structure revision and biological activity.

Authors:  Matteo Simone; Sonia I Maffioli; Arianna Tocchetti; Stefano Tretter; Monica Cattaneo; Ida Biunno; Eleonora Gaspari; Stefano Donadio
Journal:  J Antibiot (Tokyo)       Date:  2015-01-14       Impact factor: 2.649

Review 2.  Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria.

Authors:  Nina Bionda; Jean-Philippe Pitteloud; Predrag Cudic
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

Review 3.  Surfactants tailored by the class Actinobacteria.

Authors:  Johannes H Kügler; Marilize Le Roes-Hill; Christoph Syldatk; Rudolf Hausmann
Journal:  Front Microbiol       Date:  2015-03-19       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.